As this happened, UBS downgraded its Ambev S.A. ADR [ABEV] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in early April from “an Equal-weight” to “an Underweight”. BofA Securities also remained covering ABEV and has decreased its forecast on January 17, 2025 with a “Neutral” recommendation from previously “Buy” rating. Barclays revised its rating on March 04, 2024. It rated ABEV as “an Equal weight” which previously was an “an Overweight”.
Price Performance Review of ABEV
On Tuesday, Ambev S.A. ADR [NYSE:ABEV] saw its stock fall -1.18% to $2.52. Ambev S.A. ADR shares have risen nearly 36.22% since the year began. Nevertheless, the stocks have risen 7.51% over the past one year. While a 52-week high of $2.63 was reached on 05/08/25, a 52-week low of $1.76 was recorded on 01/03/25. SMA at 50 days reached $2.39, while 200 days put it at $2.21.
Levels Of Support And Resistance For ABEV Stock
The 24-hour chart illustrates a support level at 2.50, which if violated will result in even more drops to 2.48. On the upside, there is a resistance level at 2.54. A further resistance level may holdings at 2.56. The Relative Strength Index (RSI) on the 14-day chart is 59.46, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 58.97%. Stochastics %K at 51.28% indicates the stock is a holding.
